Meros Investment Management’s Harvard Bioscience HBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$577K	Sell	118,522 -3,241	-3%	-$18.1K	0.25%	50
2025 Q4	$814K	Buy	121,763 +29,937	+33%	+$178K	0.32%	44
2025 Q3	$403K	Sell	91,826 -169	-0.2%	-$802	0.17%	42
2025 Q2	$408K	Buy	91,995 +12,527	+16%	+$52.3K	0.19%	40
2025 Q1	$450K	Sell	79,468 -1,903	-2%	-$24.4K	0.26%	38
2024 Q4	$1.72M	Sell	81,371 -1,988	-2%	-$45.7K	0.77%	36
2024 Q3	$2.24M	Sell	83,359 -162	-0.2%	-$4.77K	1.01%	36
2024 Q2	$2.38M	Buy	83,521 +1,342	+2%	+$47.1K	1.13%	34
2024 Q1	$3.48M	Buy	82,179 +204	+0.2%	+$9.17K	1.56%	29
2023 Q4	$4.39M	Buy	81,975 +1,263	+2%	+$57K	2.08%	22
2023 Q3	$3.47M	Sell	80,712 -589	-0.7%	-$27.2K	1.89%	25
2023 Q2	$4.46M	Sell	81,301 -31,120	-28%	-$1.71M	2.21%	24
2023 Q1	$4.72M	Sell	112,421 -1,264	-1%	-$37.5K	2.69%	18
2022 Q4	$3.15M	Buy	113,685 +40,042	+54%	+$987K	1.86%	25
2022 Q3	$1.89M	Buy	73,643 +11,445	+18%	+$379K	1.94%	26
2022 Q2	$2.24M	Buy	62,198 +9,639	+18%	+$435K	2.08%	27
2022 Q1	$3.26M	Buy	52,559 +9,314	+22%	+$551K	2.58%	18
2021 Q4	$3.05M	Buy	+43,245	New	+$3.07M	2.23%	22